Pharma News India

The Indian drug firm has bagged the tender for the two year period starting January 1, 2013 to December 31, 2014.

Hyderabad, December 1, 2012: Mylan Laboratories Ltd will soon become one of the lead suppliers of anti-retroviral (ARV) drugs to South African Department of Health. It is to be noted here that the company has bagged the contract for two years i.e. 2013-14.


The British drug firm plans to increase its stake to 75 per cent with this investment.

Mumbai, November 27, 2012: GlaxoSmithKline (GSK) has announced that the company will be investing around Rs 5,215 crore (US$ 941 million) in its Indian consumer healthcare subsidiary, taking its total stake in the company to 75 per cent through a voluntary open offer.


With approval from COS and EQDM, Elder Pharma is set to enter regulated markets of European Union.

Mumbai, November 25, 2012: After securing the receipt of Certificate of Suitability (COS) from European Directorate for the Quality of Medicines and Healthcare (EDQM) for Diosmin API, Elder Pharma is all set to enter the regulated markets of the European Union (EU).


As a major step towards consolidating its international business, Cipla is buying 51 per cent of Cipla Medpro.

Mumbai, November 22, 2012: In a bid to consolidate its international business, Cipla is buying 51 per cent stake in South Africa's Cipla Medpro for US$ 220 million. This is Cipla's first international acquisition in the 75 year old history of the company. The deal has val...


With India being the largest exporter of generic formulations, the Indian pharma exports are expected to reach US$ 25 billion by 2014-15.

Mumbai, November 21, 2012: The Indian pharmaceutical exports are expected to reach US$ 25 billion by the end of 2014-15.


Comment!

 
 






* Indicates mandatory field.
Please wait while comments are being sent...